Alex Dudov
⬤ Hims & Hers Health Inc. has seen some serious insider selling over the last 52 weeks. According to market data, company insiders unloaded roughly $190 million worth of HIMS shares during this period. The transaction records show repeated sell-offs throughout the year, but here's the kicker – there wasn't a single insider purchase to balance things out.
⬤ The numbers paint a clear picture: insiders sold about 3.91 million shares at an average price of around $48.72 per share, with the most recent sale happening on February 3, 2026. During this entire stretch, the buy side remained completely empty – zero purchases, zero dollars invested back into the company by those who know it best.
⬤ It's not just insiders heading for the exits. Institutional ownership took a notable hit in the fourth quarter of 2025, meaning the big money players were also reducing their stakes. When both groups move in the same direction, it's worth paying attention.
⬤ This double retreat from HIMS shares tells a story about changing confidence levels. When company insiders consistently sell without any buying, and institutions follow suit by trimming positions, it typically creates headwinds for the stock and can make other investors think twice before jumping in.
Alex Dudov
